日本新薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/08/28 | 6,450 | 6,460 | 6,370 | 6,400 | -10 | -0.2% | 109,700 |
| 2018/08/27 | 6,330 | 6,440 | 6,280 | 6,410 | +110 | +1.7% | 123,000 |
| 2018/08/24 | 6,260 | 6,390 | 6,250 | 6,300 | +90 | +1.4% | 130,500 |
| 2018/08/23 | 6,210 | 6,260 | 6,190 | 6,210 | ±0 | ±0% | 79,700 |
| 2018/08/22 | 6,080 | 6,230 | 6,080 | 6,210 | +120 | +2% | 169,300 |
| 2018/08/21 | 6,120 | 6,130 | 6,040 | 6,090 | -70 | -1.1% | 165,200 |
| 2018/08/20 | 6,170 | 6,260 | 6,150 | 6,160 | -20 | -0.3% | 158,400 |
| 2018/08/17 | 6,050 | 6,200 | 6,030 | 6,180 | +120 | +2% | 175,400 |
| 2018/08/16 | 6,140 | 6,160 | 6,050 | 6,060 | -140 | -2.3% | 147,900 |
| 2018/08/15 | 6,160 | 6,300 | 6,160 | 6,200 | +20 | +0.3% | 166,400 |
| 2018/08/14 | 6,110 | 6,230 | 6,100 | 6,180 | +120 | +2% | 132,400 |
| 2018/08/13 | 6,130 | 6,180 | 6,040 | 6,060 | -140 | -2.3% | 229,000 |
| 2018/08/10 | 6,360 | 6,420 | 6,170 | 6,200 | -180 | -2.8% | 216,500 |
| 2018/08/09 | 6,430 | 6,470 | 6,210 | 6,380 | -110 | -1.7% | 260,500 |
| 2018/08/08 | 6,210 | 6,690 | 6,180 | 6,490 | +410 | +6.7% | 584,000 |
| 2018/08/07 | 6,040 | 6,180 | 5,930 | 6,080 | -20 | -0.3% | 435,400 |
| 2018/08/06 | 6,150 | 6,170 | 6,080 | 6,100 | -90 | -1.5% | 124,800 |
| 2018/08/03 | 6,200 | 6,230 | 6,160 | 6,190 | +10 | +0.2% | 105,400 |
| 2018/08/02 | 6,350 | 6,360 | 6,150 | 6,180 | -170 | -2.7% | 160,600 |
| 2018/08/01 | 6,400 | 6,460 | 6,330 | 6,350 | ±0 | ±0% | 118,900 |
| 2018/07/31 | 6,340 | 6,390 | 6,290 | 6,350 | +30 | +0.5% | 198,700 |
| 2018/07/30 | 6,540 | 6,540 | 6,250 | 6,320 | -260 | -4% | 310,300 |
| 2018/07/27 | 6,480 | 6,600 | 6,310 | 6,580 | +40 | +0.6% | 447,800 |
| 2018/07/26 | 6,430 | 6,570 | 6,400 | 6,540 | +270 | +4.3% | 435,400 |
| 2018/07/25 | 6,120 | 6,340 | 6,060 | 6,270 | +150 | +2.5% | 355,600 |
| 2018/07/24 | 6,220 | 6,270 | 6,110 | 6,120 | -80 | -1.3% | 257,700 |
| 2018/07/23 | 6,090 | 6,210 | 6,040 | 6,200 | +100 | +1.6% | 235,300 |
| 2018/07/20 | 6,140 | 6,140 | 5,970 | 6,100 | -40 | -0.7% | 267,500 |
| 2018/07/19 | 6,280 | 6,290 | 6,080 | 6,140 | -240 | -3.8% | 287,600 |
| 2018/07/18 | 6,350 | 6,490 | 6,310 | 6,380 | +160 | +2.6% | 518,600 |
| 2018/07/17 | 6,030 | 6,230 | 5,980 | 6,220 | +210 | +3.5% | 350,200 |
| 2018/07/13 | 6,130 | 6,170 | 5,890 | 6,010 | -170 | -2.8% | 348,500 |
| 2018/07/12 | 6,050 | 6,200 | 6,000 | 6,180 | +150 | +2.5% | 325,000 |
| 2018/07/11 | 6,070 | 6,070 | 5,970 | 6,030 | -100 | -1.6% | 397,400 |
| 2018/07/10 | 6,260 | 6,270 | 6,130 | 6,130 | -130 | -2.1% | 411,900 |
| 2018/07/09 | 6,530 | 6,570 | 6,190 | 6,260 | -200 | -3.1% | 385,300 |
| 2018/07/06 | 6,510 | 6,530 | 6,290 | 6,460 | -50 | -0.8% | 417,300 |
| 2018/07/05 | 6,480 | 6,550 | 6,400 | 6,510 | +50 | +0.8% | 339,400 |
| 2018/07/04 | 6,220 | 6,470 | 6,220 | 6,460 | +240 | +3.9% | 476,400 |
| 2018/07/03 | 6,500 | 6,580 | 6,120 | 6,220 | -380 | -5.8% | 688,600 |
| 2018/07/02 | 6,840 | 6,960 | 6,570 | 6,600 | -280 | -4.1% | 1,004,700 |
| 2018/06/29 | 6,780 | 6,930 | 6,510 | 6,880 | +80 | +1.2% | 746,100 |
| 2018/06/28 | 6,660 | 6,920 | 6,600 | 6,800 | +390 | +6.1% | 1,121,700 |
| 2018/06/27 | 6,350 | 6,530 | 6,340 | 6,410 | +80 | +1.3% | 318,200 |
| 2018/06/26 | 6,300 | 6,370 | 6,270 | 6,330 | -30 | -0.5% | 333,400 |
| 2018/06/25 | 6,540 | 6,550 | 6,300 | 6,360 | -100 | -1.5% | 243,600 |
| 2018/06/22 | 6,420 | 6,540 | 6,400 | 6,460 | -10 | -0.2% | 278,000 |
| 2018/06/21 | 6,570 | 6,730 | 6,430 | 6,470 | ±0 | ±0% | 360,800 |
| 2018/06/20 | 6,210 | 6,610 | 6,160 | 6,470 | -440 | -6.4% | 1,164,900 |
| 2018/06/19 | 7,160 | 7,170 | 6,810 | 6,910 | -400 | -5.5% | 415,300 |
1651～
1700
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「日本新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 168,300円 | +5.0% | +1.5% | 0.00% | 14.40倍 | 3.83倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
市場注目の銘柄
チャート関連のコラム
